NICE issues Appraisal Consultation Document on dapagliflozin for type 2 diabetes and requests more information from the manufacturer
Source: NICE
Area: News
The National Institute for Health and Clinical Excellence (NICE) has issued for consultation an Appraisal Consultation Document (ACD) on the use of dapagliflozin for type 2 diabetes.
The following preliminary recommendations have been made:
. The Committee is minded not to recommend dapagliflozin in combination therapy for treating type 2 diabetes.
. The Committee recommends that NICE requests further clarification from the manufacturers, which should be made available for the second Appraisal Committee meeting on the 5th March 2013
The consultation period closes on 22 February 2013
Source: NeLM - News - Category: Drugs & Pharmacology Source Type: news